Impaired cellular energy supply

Stage 1. Suppression of ATP resynthesis

The primary link of any energy deficit is the inhibition of ATP molecule restoration. The process breaks down directly inside the mitochondria. Normally, complex biochemical cascades take place there, but in pathology, the reactions of the Krebs cycle are disrupted, electron transport to molecular oxygen is halted, and the coupling between oxidation and ADP phosphorylation (the ATP formation process) is uncoupled.

There are four main causes of such a failure:

• Oxygen deficit (development of hypoxia, impairing aerobic oxidation).
• Lack of metabolic substrates (the cell lacks basic "fuel", such as glucose or fatty acids).
• Inhibition of enzyme activity (the work of tissue respiration and glycolysis catalysts decreases).
• Damage and destruction of mitochondria (structural defects of the cell's main power plants make normal synthesis impossible).

Stage 2. Blockade of energy transport

There is an important paradox: cellular dysfunction can develop even with normal or increased ATP content in the cell. This occurs when high-energy bonds cannot reach from the production site (mitochondria and cytosol) to the consumers—effector structures like ion pumps or myofibrils.

Normally, logistics rely on the creatine phosphate shuttle mechanism:

1. Inside the mitochondrion (in the matrix and on the inner membrane), oxidative phosphorylation takes place. ATP is synthesized from metabolic substrates, oxygen, and inorganic phosphate, and by-products such as carbon dioxide and water are formed.
2. The enzyme creatine phosphokinase (CPK) catalyzes the transfer of a phosphate group from fresh ATP to creatine, forming creatine phosphate and an ADP molecule.
3. Using ADP-ATP translocase (adenine nucleotide translocase), the nucleotides cross the membrane. Energy exits into the cytoplasm specifically as creatine phosphate.
4. Near the consumer organelles, the same CPK performs the reverse reaction: creatine phosphate transfers its phosphate to an ADP molecule, instantly resynthesizing ATP right at the site of work.
5. ATP is used by energy-dependent structures, breaking down into ADP, and free creatine returns to the mitochondria for a new cycle.

If transport enzymes (CPK or translocase) are damaged, delivery is blocked, causing acute functional failure.

Stage 3. Impairment of energy utilization

The third level of the problem is the inability of effector structures to utilize the energy already delivered. Disorders develop because the cell cannot use the available reserve. The main mechanism lies in a drop in the activity of ATPases—specific enzymes that cleave ATP to perform useful work.

Depending on which ATPase is affected, different disorders develop:

• Myosin ATPase: contractile function suffers (especially critical for muscle tissue, which loses the ability to contract).
• Na+, K+-ATPase of the plasmalemma: membrane potential is disrupted, the cell loses its normal excitability and ability to conduct impulses.
• Ca2+-ATPase (calcium pump): calcium homeostasis is broken, leading to its excessive accumulation in the cytoplasm.
• Proton and potassium ATPases: the overall ionic balance of the cell is disrupted.

It is the total damage to enzyme systems and cell membranes that is the key link that transitions functional disorders into the stage of irreversible changes and inevitably leads to cell death.

Briefly: answers to topical questions

Class and exam questions

What else to study on this topic

• Mechanisms of cellular hypoxia development
• Pathogenesis of mitochondrial membrane damage
• The role of the creatine phosphate shuttle in muscle tissue
• Impairment of calcium homeostasis in Ca2+-ATPase dysfunction
• The relationship between energy deficit and irreversible changes in the cell

Other topics in "Chapter 4: Cell Injury as the Basis for the Development of Various Forms of Human Pathology"

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.